‘They accepted the money but didn’t take care of my child’: what Luna Wong’s death reveals about the treatment of international students in the UK - The Guardian

SupercarsAnd it’s a full production supercar, not a limited-edition hypertoy. OooftPublished: 15 Oct 2026Porsche is on the ropes. Its profits – once the envy of many a carmaker – fell off a cliff last year, plunging a whopping 93 per cent to €90m. Its bet on an EV future resulted in… two new petrol crossovers. It’s now on a mission to turn the ship around. And this is part of the solution. Welcome to the stunning new Mission S supercar. Advertisement - Page continues belowIt’s not a limited-edition hypertoy conceived for the fortunate few (though no doubt it’d sell out in seconds), but a full-production car that’ll sit at the top of Porsche tree. Which means it’ll look down on Porsche’s halo car. “The Mission S represents a mid-engined super sports car platform positioned above the 911 – not as a one-off hypercar, but as a permanent and versatile addition to our customer offering,” said boss Michael Leiters. You might likeIt was designed to be “recognisable as a Porsche at first glance”, and we’d say… mission accomplished. It’s very 911-alike at the front with that familiar headlight arrangement, a slatted bonnet, a clean front bumper, and what Porsche deems ‘torpedo’ wings.

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.